Logo

American Heart Association

  34
  0


Final ID:

Translating learning from traditional biomarker discovery to novel precision tools

  • Natarajan, Pradeep  ( Massachusetts General Hospital , Brookline , Massachusetts , United States )
  • Leopold, Jane  ( Brigham and Womens Hospital , Boston , Massachusetts , United States )
  • Author Disclosures:
    Pradeep Natarajan: DO have relevant financial relationships ; Researcher:Amgen, Genentech / Roche:Active (exists now) ; Other (please indicate in the box next to the company name):Vertex Pharmaceuticals (spousal employment):Active (exists now) ; Ownership Interest:Bolt, Candela, Mercury, MyOme, Parameter Health, Preciseli, TenSixteen Bio:Active (exists now) ; Consultant:Allelica, CRISPR Therapeutics, Genentech/Roche, HeartFlow, Magnet Biomedicine:Past (completed) ; Consultant:AstraZeneca, Blackstone Life Sciences, Bristol Myers Squibb, Eli Lilly & Co, Esperion Therapeutics, Foresite Capital, Foresite Labs, GV, Merck, Novartis, Novo Nordisk, TenSixteen Bio, Tourmaline Bio:Active (exists now) ; Researcher:Allelica, Novartis:Past (completed) | Jane Leopold: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

AI-enabled Risk Prediction in Cardiovascular Care

Monday, 11/10/2025 , 01:30PM - 02:45PM

Cardiovascular Seminar

You have to be authorized to contact abstract author. Please, Login
Not Available